MLchartDataset catalogue

Hydrazine sulfate

Term · Oncology and biomedicine · MLC-T-ONC-004034

  1. A substance that has been studied as a treatment for cancer and as a treatment for cachexia (body wasting) associated with advanced cancer.

  2. The synthetic sulfate salt of hydrazine, a derivative of ammonia. Hydrazine inhibits the enzyme phosphoenol pyruvate carboxykinase, thereby blocking gluconeogenesis. This agent has been reported to decrease the excessive energy needs and cachexia of cancer patients. Classified as a likely human carcinogen, hydrazine sulfate is also a weak inhibitor of mono-amine oxidase (MAO).

Table 1. Record
IdentifierMLC-T-ONC-004034
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-004034",
  "term": "Hydrazine sulfate",
  "field": "Oncology and biomedicine",
  "definitions": [
    "A substance that has been studied as a treatment for cancer and as a treatment for cachexia (body wasting) associated with advanced cancer.",
    "The synthetic sulfate salt of hydrazine, a derivative of ammonia. Hydrazine inhibits the enzyme phosphoenol pyruvate carboxykinase, thereby blocking gluconeogenesis. This agent has been reported to decrease the excessive energy needs and cachexia of cancer patients. Classified as a likely human carcinogen, hydrazine sulfate is also a weak inhibitor of mono-amine oxidase (MAO)."
  ],
  "references": [
    "NCI Dictionary of Cancer Terms",
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/hydrazine-sulfate/"
}

Record 8,785 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.